MUC1 and pancreatic intraductal papillary-mucinous neoplasm: They observed higher MUC-1 concentrations in patients with PC or intraductal papillary mucinous carcinoma (IPMC) than in those with inflammatory pancreatic lesion or IPMN, reporting sensitivity, specificity, and accuracy values for MUC-1 (with a 16 U/mL cut-off) of 79.5%, 64.5%, and 72.9%, respectively.